Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: Course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1321-1328

  Canaud, Guillaume ^a,b   Dion, Daniel ^c   Zuber, Julien ^a,b   Gubler, Marie Claire ^d   Sberro, Rebecca ^a,b   Thervet, Eric ^a,b   Snanoudj, Renaud ^a   Charbit, Marina ^a   Salomon, Rémi ^a,b   Martinez, Frank ^a   Legendre, Christophe ^a,b   Noel, Laure Helene ^c   Niaudet, Patrick ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c U574 ^*  (France)

^d INSERM   (France)

Author keywords

FSGS; Histopathology; Kidney transplantation; Recurrence

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; ENALAPRIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEPHRIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; CHILD; DISEASE CLASSIFICATION; DRUG MEGADOSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENETIC POLYMORPHISM; GLOMERULUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT SURVIVAL; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; PROGNOSIS; PROTEINURIA; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77950212575     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp500     Document Type: Article

References (35)

1. Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2007; 2: 529-542
2. Habib R, Levy M, Gubler MC. Clinicopathologic correlations in the nephrotic syndrome. Paediatrician 1979; 8: 325-348
3. Cameron JS. The enigma of focal segmental glomerulosclerosis. Kidney Int Suppl 1996; 57: S119-S131
4. Howie AJ. Segmental sclerosing glomerular lesions. Pediatr Nephrol 1993; 7: 370-374
5. Kashgarian M, Hayslett JP, Siegel NJ. Lipoid nephrosis and focal sclerosis distinct entities or spectrum of disease. Nephron 1974; 13: 105-108
6. Cho MH, Hong EH, Lee TH, et al. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.Nephrol-ogy (Carlton) 2007; 12 (Suppl 3): S11-S14
7. Tejani A. Morphological transition in minimal change nephrotic syndrome. Nephron 1985; 39: 157-159
8. Ingulli E, Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children-a single-center experience. Transplantation 1991; 51: 401-405
9. Pardon A, et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006; 21: 1053-1059
10. Cameron JS, Senguttuvan P, Hartley B, et al.Focal segmental glomeru-losclerosis in fifty-nine renal allografts from a single centre; analysis of risk factors for recurrence. Transplant Proc 1989; 21(Pt 2): 2117-2118
11. Dantal J, Baatard R, Hourmant M, et al. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomeruloscle-rosis. A one-center study of plasma exchange effects. Transplantation 1991; 52: 827-831
12. Dantal J, Soulillou JP. Relapse of focal segmental glomerulosclerosis after kidney transplantation. Adv Nephrol Necker Hosp 1996; 25: 91-106
13. Tejani A, Stablein DH. Recurrence of focal segmental glomeruloscle-rosis posttransplantation: a special report of the North American Pe-diatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992; 2(Suppl 12): S258-S263
14. Artero M, et al. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92: 375-383
15. D'Agati VD, Fogo AB, Bruijn JA, et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004; 43: 368-382
16. Howie AJ, Pankhurst T, Sarioglu S, et al. Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int 2005; 67: 987-1001
17. Beaman M, Howie AJ, Hardwicke J, et al. The glomerular tip lesion: a steroid responsive nephrotic syndrome. Clin Nephrol 1987; 27: 217-221
18. Detwiler RK, Falk RJ, Hogan SL, et al. Collapsing glomerulopa-thy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 1994; 45: 1416-1424
19. Schwartz MM, Lewis EJ. Focal segmental glomerular sclerosis: the cellular lesion. Kidney Int 1985; 28: 968-974
20. Fuiano G, et al. Serial morphometric analysis of sclerotic lesionsin primary 'focal' segmental glomerulosclerosis. J Am Soc Nephrol 1996; 7: 49-55
21. Ijpelaar DH, et al. Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol 2008
22. Tonna SJ, et al. NPHS2 variation in focal and segmental glomeru-losclerosis. BMC Nephrol 2008; 9: 13
23. Thomas DB, Franceschini N, Hogan SL, et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 2006; 69: 920-926
24. Stokes MB, Valeri AM, Markowitz GS, et al. Cellular focal segmental glomerulosclerosis: clinical and pathologic features. Kidney Int 2006; 70: 1783-1792
25. Silverstein DM, CraverR. Presenting features and short-termoutcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2007; 2: 700-707
26. D'Agati V. Pathologic classification of focal segmental glomeru-losclerosis. Semin Nephrol 2003; 23: 117-134
27. Canaud G, Zuber J, Sberro R, et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant 2009; 9: 1081-1086
28. Salomon R, Gagnadoux MF, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003; 75: 810-814
29. Yabu JM, Ho B, Scandling JD, et al. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008; 8: 222-227
30. Kamar N, Faguer S, Esposito L, et al. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 2007; 67: 250-254
31. Nadasdy T, Allen C, Zand MS. Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes. Hum Pathol 2002; 33: 437-441
32. Goes NB, Colvin RB. Case records of the Massachusetts General Hospital. Case 12-2007. A 56-year-old woman with renal failure after heart-lung transplantation. N Engl J Med 2007; 356: 1657-1665
33. Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40: 1175-1184
34. Fine RN. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pe-diatr Nephrol 2007; 22: 496-502
35. Stokes MB, Markowitz GS, Lin J, et al. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomeru-losclerosis spectrum. Kidney Int 2004; 65: 1690-1702